Results 271 to 280 of about 5,752,243 (395)

An Autopsy Case of Multiple Myeloma

open access: bronze, 1961
吉岡 俊夫   +3 more
openalex   +2 more sources

Tumor growth patterns in multiple myeloma [PDF]

open access: bronze, 1977
Jim Hokanson   +4 more
openalex   +1 more source

The regulatory effects and applications of TIGIT/CD155 on the tumor microenvironment in HCC

open access: yesVIEW, EarlyView.
Background The interaction between TIGIT and CD155 compromises immune cell efficacy in tumor targeting, potentially driving hepatocellular carcinoma (HCC) progression through diverse molecular pathways. What Was Done This study investigates the interplay between CD155 and TIGIT in regulating CD8+ T cell function and elucidates its implications in HCC ...
Wenting Li   +10 more
wiley   +1 more source

A Case of Multiple Myeloma

open access: bronze, 1965
Michio Yamamoto   +3 more
openalex   +2 more sources

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

open access: yesVIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma   +6 more
wiley   +1 more source

A CASE OF MINOR ANOMALY TYPE MULTIPLE MYELOMA COMPLICATED WITH PULMONARY EMBOLISM

open access: bronze, 1968
Tadamasa Tozuka   +7 more
openalex   +2 more sources

Long‐term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract An 8‐year‐old Staffordshire bull terrier presented for left submandibular lymphadenopathy. Cytology showed a monomorphic population of mature plasma cells suggestive of plasma cell neoplasia. On physical examination, no other lymphadenomegaly, cutaneous or oral lesions were found.
Celia Figueroa‐González   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy